Quantum computing is poised to become a catalytic force in the global pharmaceuticals and biotechnology industries. Its ability to tackle problems of staggering complexity – whether simulating the quantum behavior of drug molecules, analyzing massive genomic datasets for personalized medicine, or optimizing the myriad decisions in R&D and supply chains – offers a new computational paradigm for an innovation-hungry sector. We have seen that even in its nascent state, quantum technology is already making waves: early experiments have accelerated molecular discovery, quantum sensors are breaking new ground in biomedical imaging​, and companies big and small are gearing up through partnerships and pilot projects to be part of this coming revolution​​ ...